These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 36335825)

  • 1. The effects on type 2 diabetes mellitus mouse femoral bone achieved by anti-osteoporosis exercise interventions.
    Zhang M; Li Y; Liu L; Huang M; Wang M; Zou J
    Front Endocrinol (Lausanne); 2022; 13():914872. PubMed ID: 36465647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise initiated after the onset of insulin resistance improves trabecular microarchitecture and cortical bone biomechanics of the tibia in hyperphagic Otsuka Long Evans Tokushima Fatty rats.
    Ortinau LC; Linden MA; Dirkes RK; Rector RS; Hinton PS
    Bone; 2017 Oct; 103():188-199. PubMed ID: 28711659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate intensity aerobic training reduces the signs of peripheral sensitization in a mouse model of type 2 diabetes mellitus.
    Pérez-Martinez IO; Cifuentes-Mendiola SE; Solis-Suarez DL; García-Hernández AL
    Exp Brain Res; 2022 Oct; 240(10):2747-2756. PubMed ID: 36063191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular Complications in Individuals with Type 2 Diabetes Mellitus Additionally Increase the Risk of Femoral Neck Fractures Due to Deteriorated Trabecular Microarchitecture.
    Cirovic A; Vujacic M; Petrovic B; Cirovic A; Zivkovic V; Nikolic S; Djonic D; Bascarevic Z; Djuric M; Milovanovic P
    Calcif Tissue Int; 2022 Jan; 110(1):65-73. PubMed ID: 34302494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.
    Dadmanesh M; Aghajani H; Fadaei R; Ghorban K
    PLoS One; 2018; 13(9):e0204180. PubMed ID: 30212581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerobic training improves bone fragility by reducing the inflammatory microenvironment in bone tissue in type 2 diabetes.
    Cifuentes-Mendiola SE; Solís-Suárez DL; Martínez-Dávalos A; Perrusquía-Hernández E; García-Hernández AL
    J Biomech; 2022 Dec; 145():111354. PubMed ID: 36335825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis.
    Liu C; Feng X; Li Q; Wang Y; Li Q; Hua M
    Cytokine; 2016 Oct; 86():100-109. PubMed ID: 27498215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Aerobic and Resistant Exercise Intervention on Inflammaging of Type 2 Diabetes Mellitus in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis.
    Xing H; Lu J; Yoong SQ; Tan YQ; Kusuyama J; Wu XV
    J Am Med Dir Assoc; 2022 May; 23(5):823-830.e13. PubMed ID: 35183493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility.
    Eller-Vainicher C; Cairoli E; Grassi G; Grassi F; Catalano A; Merlotti D; Falchetti A; Gaudio A; Chiodini I; Gennari L
    J Diabetes Res; 2020; 2020():7608964. PubMed ID: 32566682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Necrosis Factor-Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus.
    Akash MSH; Rehman K; Liaqat A
    J Cell Biochem; 2018 Jan; 119(1):105-110. PubMed ID: 28569437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipokines as potential biomarkers for type 2 diabetes mellitus in cats.
    Sierawska O; Niedźwiedzka-Rystwej P
    Front Immunol; 2022; 13():950049. PubMed ID: 36248900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture Risk Assessment in Patients With Diabetes Mellitus.
    Poiana C; Capatina C
    J Clin Densitom; 2017; 20(3):432-443. PubMed ID: 28716499
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.